Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Operating Activities:      
Net loss $ (5,514) $ (6,989)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Share-based compensation 971 1,301  
Amortization of debt discount 402 536  
Amortization of debt issuance costs 112 113  
Change in fair value of derivative liability (8) (1,138)  
Debt extinguishment, net 144  
Depreciation and amortization 655 409  
Loss on lease termination 22  
Loss on disposal of property and equipment 10  
Allowance for doubtful accounts 77 189  
Effect of changes in assets and liabilities:      
Accounts receivable (304) (343)  
Prepaid expenses and other current assets 63 128  
Operating lease right-of-use assets 102 86  
Accounts payable, accrued expenses, and accrued interest 406 237  
Contract liabilities 105 76  
Deferred incentive compensation (377)  
Operating lease liabilities (129) (159)  
Net cash used in operating activities (2,918) (5,899)  
Investing Activities:      
Proceeds from sale of property and equipment 3  
Capitalized software development costs (126) (2,284)  
Purchases of tangible and intangible assets (5) (82)  
Net cash used in investing activities (131) (2,363)  
Financing Activities:      
Proceeds from sale of common stock 6,578 7,538  
Proceeds from sale of Series B redeemable preferred stock 5  
Proceeds from convertible notes payable 6,000  
Proceeds from advances on future receipts 290  
Payment of advances on future receipts (1,026) (2,507)  
Payment on convertible notes payable (1,350)  
Proceeds from option exercise 377  
Payment for debt issuance costs (87) (365)  
Net cash provided by financing activities 4,410 11,043  
Net change in cash 1,361 2,781  
Cash - beginning of period 2,429 937 $ 937
Cash - end of period $ 3,790 $ 3,718 $ 2,429